Rediff
Home Mail
NewsBusinessMoviesCricketSportsGetahead
Money HomeNewsForexIndicesMutual FundsInsuranceGainersLosers
TrendsStar PortfoliosMy PortfolioMy Watchlist
BusinessEmailGurusTV
News >
Headlines Defence Images Columns Interviews Specials Coverage Videos Archives
Business >
Headlines Columns Specials Personal Finance Interviews Images Technology Auto Union Budget 2026 Archives
Movies >
Headlines Images Interviews Reviews Web Series Videos South Cinema Quiz Hollywood Archives
Cricket >
Headlines Images Stats Women's T20 WC 2026 WT20 2026: Games, Players, Teams IPL 2026 Archives
Sports >
Headlines Formula 1 Football Tennis Chess Hockey
Get Ahead >
Headlines Specials Careers Glamour Health Achievers Finance Travel Food Videos Gadgets Biking Relationships Archives
Money >
News Forex Indices Sectors Mutual Funds Insurance Gainers Losers Trends Star Portfolios My Portfolio My Watchlist
More
Mail Business Email Gurus TV Rediff Podcast
Top StoriesNewsBusinessCricketMoviesSportsGet ahead
  • Headlines
  • Defence
  • Images
  • Columns
  • Interviews
  • Specials
  • Archives

News for 'drug supply chain'

India's upward Covid-19 trend a cause of worry: Govt

India's upward Covid-19 trend a cause of worry: Govt

Rediff.com13 Apr 2021

Giving details of coronavirus situation in the country, Bhushan said the previous highest surge has already been crossed and the trend is going upward and that is a cause for worry and that is something they continuously share with the states and UTs and try to help them tackle the pandemic in a more effective manner.

China is the dragon in ASEAN room

China is the dragon in ASEAN room

Rediff.com18 Nov 2020

Had India agreed to join the trade pact, Indian markets would have been flooded with cheap Chinese products.

The Sooner Woke-dom Dies, The Better

The Sooner Woke-dom Dies, The Better

Rediff.com11 Feb 2022

As far as Hindus are concerned, the eclipse of Wokeism cannot come any sooner, says Rajeev Srinivasan.

2nd wave subsiding, but can't say worst is over: Govt

2nd wave subsiding, but can't say worst is over: Govt

Rediff.com17 Oct 2021

Cautioning that the country is passing through a phase when there are festivals and potential gatherings, he said this is a critical phase as the virus can spread again.

Govt likely to fast-track import restrictions on 371 Chinese goods

Govt likely to fast-track import restrictions on 371 Chinese goods

Rediff.com30 Jun 2020

The government has been gearing up to place tighter restrictions on the import of 371 items - ranging from toys and plastic goods to sports items, and furniture worth $127 billion.

Chinese FM bats for enhancing ties with India, Russia

Chinese FM bats for enhancing ties with India, Russia

Rediff.com24 Jun 2020

In his address to RIC Foreign Ministers, Wang said the three countries should 'correctly handle and properly deal with sensitive factors in bilateral relations and safeguard the overall interests of mutual relation', without directly referring to the current round of India-China military tensions along the Line of Actual Control, (LAC).

Gujarat pharma hub hit by near-zero exports

Gujarat pharma hub hit by near-zero exports

Rediff.com15 Apr 2020

With the government asking the companies to operate with only 50 per cent staff strength, and exports dipping to almost zero, the truck and bus drivers idling at the petrol pump say they hardly have any work now. At a petrol pump on the deserted Bavla-Changodar highway near Ahmedabad in Gujarat, several trucks and buses are neatly parked in a row.

Pfizer says its Covid vaccine is 95% effective in final trials

Pfizer says its Covid vaccine is 95% effective in final trials

Rediff.com18 Nov 2020

Pfizer and BioNTech said they have concluded phase 3 study of their mRNA-based COVID-19 vaccine candidate BNT162b2, meeting all primary efficacy endpoints.

3 COVID vaccines under active consideration: Health ministry

3 COVID vaccines under active consideration: Health ministry

Rediff.com8 Dec 2020

Over the last four days, the Indian arm of US pharmaceutical giant Pfizer, Pune-based Serum Institute of India and Hyderabad-based pharmaceutical firm Bharat Biotech have applied to the Drugs Controller General of India seeking emergency use authorisation for their COVID-19 vaccines.

Pfizer seeks approval in India for Covid vaccine

Pfizer seeks approval in India for Covid vaccine

Rediff.com6 Dec 2020

'Pfizer India has submitted an application on December 4 to the DCGI seeking emergency use authorization for its COVID-19 vaccine in India'

After 28 days, Rhea Chakraborty steps out of jail

After 28 days, Rhea Chakraborty steps out of jail

Rediff.com7 Oct 2020

Rhea was arrested by the Narcotics Control Bureau on September 9. The NCB has accused her of procuring drugs for Rajput.

How to DEFEAT the NEXT Pandemic

How to DEFEAT the NEXT Pandemic

Rediff.com3 Nov 2021

Illustrious international thinkers met at the Milken Institute Global Conference 2021 and many discussions addressed the impact of the COVID-19 pandemic on the world at large.

'We are exploring setting up an aerotropolis'

'We are exploring setting up an aerotropolis'

Rediff.com10 Mar 2023

'We would like to develop Andhra Pradesh into a logistics hub not only for India, but also for South Asia.'

Vaccines: Look to Russia, not US!

Vaccines: Look to Russia, not US!

Rediff.com3 Jun 2021

An alert government in Delhi should have begun government-to-government discussions with Moscow the moment it came to know that Russians were developing a vaccine. That is to say, almost an year's time has been lost, observes Ambassador M K Bhadrakumar.

India may not buy Pfizer, Moderna vaccines

India may not buy Pfizer, Moderna vaccines

Rediff.com23 Sep 2021

Though there is no official word, the sources said the government is not ready to give in to the indemnity demands of the US drug manufacturers against liabilities in case of adverse effects.

Why Doctors Stopped Being Gods

Why Doctors Stopped Being Gods

Rediff.com15 Sep 2022

I got to know that every referred case for angiography and angioplasty got a kickback of Rs 5,000 and Rs 15,000 respectively. Seeing this trend, doctors started paying referring doctors Rs 1 lakh in advance and adjusting it as and when patients came in. This menace slowly spread its tentacles all over the medical field, including radiological diagnostics and biochemistry laboratories. For every test ordered, 20 per cent of the bill was given back to the referring doctor. This led to doctors recommending unnecessary tests. The pharmaceutical companies also saw burgeoning business. Acclaimed doctors were given televisions sets, refrigerators, air conditioners and cars depending upon the prescriptions. General practitioners would prescribe unnecessary drugs, and were given returns in cash. A fascinating excerpt from Dr Upendra Kaul's When The Heart Speaks.

Barber shops, e-commerce allowed in orange, green zones: MHA

Barber shops, e-commerce allowed in orange, green zones: MHA

Rediff.com2 May 2020

The MHA on Friday, while extending the lockdown for two more weeks till May 17, lifted many restrictions in green and orange zones. There are no restrictions on sale of non-essential items by e-commerce platforms in green and orange zones, a home ministry spokesperson said, adding barber shops and salons are also allowed to open in these areas.

Economic recovery still not well entrenched: RBI Guv

Economic recovery still not well entrenched: RBI Guv

Rediff.com16 Sep 2020

Observing that the economic recovery was not yet fully entrenched, the RBI Governor said recovery is likely to be gradual.

Why dealers are spooked about GST roll-out

Why dealers are spooked about GST roll-out

Rediff.com31 May 2017

FMCG, durables, pharma firms say they remain unclear about transition gains and losses

US allows 'game-changer' saliva-based Covid test

US allows 'game-changer' saliva-based Covid test

Rediff.com16 Aug 2020

The new test it will enable rapid testing amongst more people easily.

Biden unveils health team; names Vivek Murthy as surgeon general

Biden unveils health team; names Vivek Murthy as surgeon general

Rediff.com7 Dec 2020

Dr Anthony Fauci has been named as Chief Medical Adviser to the President on COVID-19, while Dr Rochelle Walensky has been named as Director of the Centers for Disease Control and Prevention; and Dr. Marcella Nunez-Smith as COVID-19 Equity Task Force Chair.

'Difference this time is the suddenness of death'

'Difference this time is the suddenness of death'

Rediff.com17 May 2021

'Now you see a patient, 10 minutes later the patient is dead.' 'The second wave is definitely much more dangerous, brutal and fatal than the first wave.' 'The number of deaths and infections in India today are very, very, high; the actual numbers are not being reported.'

Human clinical trials for COVID-19 vaccine initiated in India: ICMR

Human clinical trials for COVID-19 vaccine initiated in India: ICMR

Rediff.com14 Jul 2020

Since India is one of the largest vaccine producers in the world, it is the country's 'moral responsibility' to fast-track vaccine development process to break the chain of coronavirus transmission, ICMR Director General Dr Balram Bhargava said referring to the two vaccine candidates developed indigenously.

Which way is Covid-19 headed?

Which way is Covid-19 headed?

Rediff.com18 Mar 2020

The disease could go down several paths. One possibility, the least likely, is that it will just disappear. The most likely is that it will have seasonal impact, says Devangshu Datta.

Maha: Satara, Sangli, Panvel run out of Covid vaccine

Maha: Satara, Sangli, Panvel run out of Covid vaccine

Rediff.com8 Apr 2021

Satara, Sangli, Panvel have stopped vaccination while Buldhana has only one day's vaccine doses left in stock, said Maharashtra Health Minister Rajesh Tope.

Lupin acquires US generics firm GAVIS for $880 mn

Lupin acquires US generics firm GAVIS for $880 mn

Rediff.com24 Jul 2015

Lupin will fund the buy through $100 mn cash reserves and a bridge loan.

Why so many Indian food product exports get rejected

Why so many Indian food product exports get rejected

Rediff.com13 Sep 2016

India consistently ranked among the top three countries whose products were rejected for import by the regulator.

2024: Modi is going nowhere

2024: Modi is going nowhere

Rediff.com24 May 2021

It is too early to write Narendra Modi's political obituary, asserts Virendra Kapoor.

UK's new five pound bill sparks protest from Hindus

UK's new five pound bill sparks protest from Hindus

Rediff.com3 Dec 2016

The group has been encouraging people to sign a petition calling for the withdrawal of the notes as vegans and vegetarians continued to express outrage at the use of tallow, a substance derived from animal fat.

COVID-19 vaccine at least a year away, say scientists

COVID-19 vaccine at least a year away, say scientists

Rediff.com16 Jun 2020

According to the World Health Organisation, 10 candidate vaccines for COVID-19 are in the clinical evaluation and 126 are in the pre-clinical stage.

96,000 vaccinators trained for world's largest immunisation exercise

96,000 vaccinators trained for world's largest immunisation exercise

Rediff.com1 Jan 2021

Of the 23.9 million vaccinators who provide vaccination under the universal immunisation programme, 15.4 million will be used for Covid vaccination.

Industries in rural areas allowed to operate from April 20

Industries in rural areas allowed to operate from April 20

Rediff.com15 Apr 2020

Fresh guidelines issued by the Union home ministry on Wednesday permit industries operating in rural areas to run from April 30 with strict social distancing norms.

'After Covid, demand will be back with a vengeance'

'After Covid, demand will be back with a vengeance'

Rediff.com11 Dec 2020

'When there is unlocking, there is demand revival.' 'This is going to be the main growth engine in this kind of an economic scenario.'

Sun Pharma draws up plan to fix ailing Ranbaxy

Sun Pharma draws up plan to fix ailing Ranbaxy

Rediff.com12 Sep 2014

It hopes to turn around Ranbaxy within four years of closing the deal by improving efficiency and resolving all regulatory issues

New pressure points from going global

New pressure points from going global

Rediff.com9 Sep 2016

Our governments are easily prone to arbitrary decisions but if you are dealing with international firms, such arbitrariness can turn back and bite you, says T N Ninan.

Lockdown 3.0 begins on Monday with 'considerable relaxations'

Lockdown 3.0 begins on Monday with 'considerable relaxations'

Rediff.com3 May 2020

In containment areas, movements of people is totally banned and essential services are delivered at the doorsteps.

Bringing the phulkari back in vogue

Bringing the phulkari back in vogue

Rediff.com5 Oct 2017

A mother-daughter duo is working tirelessly to revive the art and empower rural artisans too.

Brexit brings bad news to Indian, global corporates

Brexit brings bad news to Indian, global corporates

Rediff.com24 Jun 2016

Some investors warned of a coming British or even global recession as sterling collapsed to hit its lowest since 1985.

Second dry run for Covid vaccine across India on January 8

Second dry run for Covid vaccine across India on January 8

Rediff.com6 Jan 2021

The first dry run of the vaccination drive took place across 125 districts covering all States/UTs on January 2. The dry run was also conducted to familiarise the state, district, block, and hospital-level officers on all aspects of the COVID-19 rollout.

India Inc lines up as demand for rapid testing for coronavirus grows

India Inc lines up as demand for rapid testing for coronavirus grows

Rediff.com3 Apr 2020

The test used now, called PCR (or polymerace chain reaction), uses a nasal or throat swab sample and identifies the virus. These tests take at least five hours to give results. The rapid test, on the other hand, uses a blood sample and gives results based on detecting the presence of certain antibodies that react to the coronavirus protein.

« Prev  |  Next »
Rediff
GET IT ONGoogle Play
GET IT ONApp Store
CONNECT
  • Rediffmail
  • Rediff One
  • - Rediffmail Enterprise
  • - Rediff Ecommerce
  • - Rediff HRMS
  • - Rediff CRM
  • - Rediff ERP
News
  • News
  • Business
  • Movies
  • Sports
  • Cricket
  • Get Ahead
  • Gurus
  • Astrology
  • Rediff Podcast
Stocks
  • BSE Live
  • NSE Live
  • Market News
  • Watchlist
  • Portfolio
Gurus
  • Health
  • Money
  • Career
  • Relationship
About Rediff|Advertise|Privacy Policy|Terms of Service|Investor Relations|Contact Us|© 2026 Rediff.com India Ltd. All rights reserved.